6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase
Abstract
3-Hydroxypyrimidine-2,4-dione (HPD) represents a versatile chemical core in the design of inhibitors of human immunodeficiency virus (HIV) reverse transcriptase (RT)-associated RNase H and integrase strand transfer (INST). We report herein the design, synthesis and biological evaluation of an HPD subtype (4) featuring a cyclohexylmethyl group at the C-6 position. Antiviral testing showed that most analogues of 4 inhibited HIV-1 in the low nanomolar to submicromolar range, without cytotoxicity at concentrations up to 100 μM. Biochemically, these analogues dually inhibited both the polymerase (pol) and the RNase H functions of RT, but not INST. Co-crystal structure of 4a with RT revealed a nonnucleoside RT inhibitor (NNRTI) binding mode. Interestingly, chemotype 11, the synthetic precursor of 4 lacking the 3-OH group, did not inhibit RNase H while potently inhibiting pol. Here, by virtue of the potent antiviral activity and biochemical RNase H inhibition, HPD subtype 4 could provide a viable platform for eventually achieving potent and selective RNase H inhibition through further medicinal chemistry.
- Authors:
-
- Univ. of Minnesota, Minneapolis, MN (United States)
- Univ. of Missouri School of Medicine, Columbia, MO (United States)
- Publication Date:
- Research Org.:
- Argonne National Laboratory (ANL), Argonne, IL (United States)
- Sponsoring Org.:
- USDOE Office of Science (SC); National Inst. of Health
- OSTI Identifier:
- 1349118
- Alternate Identifier(s):
- OSTI ID: 1419352
- Grant/Contract Number:
- AC02-06CH11357; AI100890
- Resource Type:
- Accepted Manuscript
- Journal Name:
- European Journal of Medicinal Chemistry
- Additional Journal Information:
- Journal Volume: 128; Journal Issue: C; Journal ID: ISSN 0223-5234
- Publisher:
- Elsevier
- Country of Publication:
- United States
- Language:
- ENGLISH
- Subject:
- 59 BASIC BIOLOGICAL SCIENCES; 3-Hydroxypyrimidine-2,4-dione (HPD); human immunodeficiency virus (HIV); RNase H; polymerase; inhibitors
Citation Formats
Tang, Jing, Kirby, Karen A., Huber, Andrew D., Casey, Mary C., Ji, Juan, Wilson, Daniel J., Sarafianos, Stefan G., and Wang, Zhengqiang. 6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase. United States: N. p., 2017.
Web. doi:10.1016/j.ejmech.2017.01.041.
Tang, Jing, Kirby, Karen A., Huber, Andrew D., Casey, Mary C., Ji, Juan, Wilson, Daniel J., Sarafianos, Stefan G., & Wang, Zhengqiang. 6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase. United States. https://doi.org/10.1016/j.ejmech.2017.01.041
Tang, Jing, Kirby, Karen A., Huber, Andrew D., Casey, Mary C., Ji, Juan, Wilson, Daniel J., Sarafianos, Stefan G., and Wang, Zhengqiang. Mon .
"6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase". United States. https://doi.org/10.1016/j.ejmech.2017.01.041. https://www.osti.gov/servlets/purl/1349118.
@article{osti_1349118,
title = {6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase},
author = {Tang, Jing and Kirby, Karen A. and Huber, Andrew D. and Casey, Mary C. and Ji, Juan and Wilson, Daniel J. and Sarafianos, Stefan G. and Wang, Zhengqiang},
abstractNote = {3-Hydroxypyrimidine-2,4-dione (HPD) represents a versatile chemical core in the design of inhibitors of human immunodeficiency virus (HIV) reverse transcriptase (RT)-associated RNase H and integrase strand transfer (INST). We report herein the design, synthesis and biological evaluation of an HPD subtype (4) featuring a cyclohexylmethyl group at the C-6 position. Antiviral testing showed that most analogues of 4 inhibited HIV-1 in the low nanomolar to submicromolar range, without cytotoxicity at concentrations up to 100 μM. Biochemically, these analogues dually inhibited both the polymerase (pol) and the RNase H functions of RT, but not INST. Co-crystal structure of 4a with RT revealed a nonnucleoside RT inhibitor (NNRTI) binding mode. Interestingly, chemotype 11, the synthetic precursor of 4 lacking the 3-OH group, did not inhibit RNase H while potently inhibiting pol. Here, by virtue of the potent antiviral activity and biochemical RNase H inhibition, HPD subtype 4 could provide a viable platform for eventually achieving potent and selective RNase H inhibition through further medicinal chemistry.},
doi = {10.1016/j.ejmech.2017.01.041},
journal = {European Journal of Medicinal Chemistry},
number = C,
volume = 128,
place = {United States},
year = {Mon Jan 30 00:00:00 EST 2017},
month = {Mon Jan 30 00:00:00 EST 2017}
}
Web of Science
Works referenced in this record:
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
journal, January 2010
- Cihlar, Tomas; Ray, Adrian S.
- Antiviral Research, Vol. 85, Issue 1
Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)
journal, January 2010
- de Béthune, Marie-Pierre
- Antiviral Research, Vol. 85, Issue 1
Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
journal, January 2016
- Ghosh, Arun K.; Osswald, Heather L.; Prato, Gary
- Journal of Medicinal Chemistry, Vol. 59, Issue 11
Review of integrase strand transfer inhibitors for the treatment of human immunodeficiency virus infection
journal, August 2015
- Park, Tae Eun; Mohamed, Abdilahi; Kalabalik, Julie
- Expert Review of Anti-infective Therapy, Vol. 13, Issue 10
Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H
journal, April 2016
- Kankanala, Jayakanth; Kirby, Karen A.; Liu, Feng
- Journal of Medicinal Chemistry, Vol. 59, Issue 10
Design, Synthesis, Biochemical, and Antiviral Evaluations of C6 Benzyl and C6 Biarylmethyl Substituted 2-Hydroxylisoquinoline-1,3-diones: Dual Inhibition against HIV Reverse Transcriptase-Associated RNase H and Polymerase with Antiviral Activities
journal, December 2014
- Vernekar, Sanjeev Kumar V.; Liu, Zheng; Nagy, Eva
- Journal of Medicinal Chemistry, Vol. 58, Issue 2
3-Hydroxypyrimidine-2,4-diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design, Synthesis, and Biochemical Evaluations
journal, March 2016
- Tang, Jing; Liu, Feng; Nagy, Eva
- Journal of Medicinal Chemistry, Vol. 59, Issue 6
3-Hydroxypyrimidine-2,4-dione-5- N -benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H
journal, June 2016
- Wu, Bulan; Tang, Jing; Wilson, Daniel J.
- Journal of Medicinal Chemistry, Vol. 59, Issue 13
Rationally Designed Dual Inhibitors of HIV Reverse Transcriptase and Integrase
journal, July 2007
- Wang, Zhengqiang; Bennett, Eric M.; Wilson, Daniel J.
- Journal of Medicinal Chemistry, Vol. 50, Issue 15
3-Hydroxypyrimidine-2,4-diones as an Inhibitor Scaffold of HIV Integrase
journal, April 2011
- Tang, Jing; Maddali, Kasthuraiah; Metifiot, Mathieu
- Journal of Medicinal Chemistry, Vol. 54, Issue 7
N-3 Hydroxylation of Pyrimidine-2,4-diones Yields Dual Inhibitors of HIV Reverse Transcriptase and Integrase
journal, October 2010
- Tang, Jing; Maddali, Kasthuraiah; Dreis, Christine D.
- ACS Medicinal Chemistry Letters, Vol. 2, Issue 1
Synthesis and biological evaluation of novel dihydro-aryl/alkylsulfanyl-cyclohexylmethyl-oxopyrimidines (S-DACOs) as high active anti-HIV agents
journal, January 2011
- He, Yan-Ping; Long, Jin; Zhang, Shui-Shuan
- Bioorganic & Medicinal Chemistry Letters, Vol. 21, Issue 2
A Safe, Economical Method for the Preparation of β-Oxo Esters
journal, January 1993
- Clay, Ronald J.; Collom, Thomas A.; Karrick, Gregory L.
- Synthesis, Vol. 1993, Issue 03
Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.
journal, January 1992
- Kimpton, J.; Emerman, M.
- Journal of Virology, Vol. 66, Issue 4
Clicking 3′-Azidothymidine into Novel Potent Inhibitors of Human Immunodeficiency Virus
journal, October 2013
- Sirivolu, Venkata Ramana; Vernekar, Sanjeev Kumar V.; Ilina, Tatiana
- Journal of Medicinal Chemistry, Vol. 56, Issue 21
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
journal, December 1983
- Mosmann, Tim
- Journal of Immunological Methods, Vol. 65, Issue 1-2
Retroviral integrase superfamily: the structural perspective
journal, January 2009
- Nowotny, Marcin
- EMBO reports, Vol. 10, Issue 2
Complexes of HIV-1 Reverse Transcriptase with Inhibitors of the HEPT Series Reveal Conformational Changes Relevant to the Design of Potent Non-Nucleoside Inhibitors
journal, January 1996
- Hopkins, Andrew L.; Ren, Jingshan; Esnouf, Robert M.
- Journal of Medicinal Chemistry, Vol. 39, Issue 8
Design of MKC-442 (Emivirine) Analogues with Improved Activity Against Drug-Resistant HIV Mutants
journal, November 1999
- Hopkins, Andrew L.; Ren, Jingshan; Tanaka, Hiromichi
- Journal of Medicinal Chemistry, Vol. 42, Issue 22
A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine
journal, December 1989
- Miyasaka, Tadashi; Tanaka, Hiromichi; Baba, Masanori
- Journal of Medicinal Chemistry, Vol. 32, Issue 12
A new class of HIV-1 specific 6-substituted acyclouridine derivatives: synthesis and anti-HIV-1 activity of 5- or 6-substituted analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)
journal, January 1991
- Tanaka, Hiromichi; Baba, Masanori; Hayakawa, Hiroyuki
- Journal of Medicinal Chemistry, Vol. 34, Issue 1
Synthesis and Antiviral Activity of 6-Benzyl Analogs of 1-[(2-Hydroxyethoxy)methyl]-5-(phenylthio)thymine (HEPT) as Potent and Selective Anti-HIV-1 Agents
journal, July 1995
- Tanaka, Hiromichi; Takashima, Hideaki; Ubasawa, Masaru
- Journal of Medicinal Chemistry, Vol. 38, Issue 15
Recent Progress in the Research of Small Molecule HIV-1 RNase H Inhibitors
journal, April 2014
- Cao, Lili; Song, Weiguo; Clercq, Erik
- Current Medicinal Chemistry, Vol. 21, Issue 17
A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity
journal, November 2003
- Parniak, Michael A.; Min, Kyung-Lyum; Budihas, Scott R.
- Analytical Biochemistry, Vol. 322, Issue 1
Determinants of Mg 2+ -Dependent Activities of Recombinant Human Immunodeficiency Virus Type 1 Integrase †
journal, August 2000
- Leh, Hervé; Brodin, Priscille; Bischerour, Julien
- Biochemistry, Vol. 39, Issue 31
Biochemical and Pharmacological Analyses of HIV-1 Integrase Flexible Loop Mutants Resistant to Raltegravir
journal, May 2010
- Métifiot, Mathieu; Maddali, Kasthuraiah; Naumova, Alena
- Biochemistry, Vol. 49, Issue 17
Preferential Inhibition of the Magnesium-Dependent Strand Transfer Reaction of HIV-1 Integrase by α-Hydroxytropolones
journal, January 2006
- Semenova, Elena A.; Johnson, Allison A.; Marchand, Christophe
- Molecular Pharmacology, Vol. 69, Issue 4
Virion Instability of Human Immunodeficiency Virus Type 1 Reverse Transcriptase (RT) Mutated in the Protease Cleavage Site between RT p51 and the RT RNase H Domain
journal, September 2005
- Abram, Michael E.; Parniak, Michael A.
- Journal of Virology, Vol. 79, Issue 18
Structural and Inhibition Studies of the RNase H Function of Xenotropic Murine Leukemia Virus-Related Virus Reverse Transcriptase
journal, January 2012
- Kirby, Karen A.; Marchand, Bruno; Ong, Yee Tsuey
- Antimicrobial Agents and Chemotherapy, Vol. 56, Issue 4
Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design
journal, August 2008
- Bauman, Joseph D.; Das, Kalyan; Ho, William C.
- Nucleic Acids Research, Vol. 36, Issue 15
XDS
journal, January 2010
- Kabsch, Wolfgang
- Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2
Phaser crystallographic software
journal, July 2007
- McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.
- Journal of Applied Crystallography, Vol. 40, Issue 4
Snapshot of the equilibrium dynamics of a drug bound to HIV-1 reverse transcriptase
journal, January 2013
- Kuroda, Daniel G.; Bauman, Joseph D.; Challa, J. Reddy
- Nature Chemistry, Vol. 5, Issue 3
PHENIX : building new software for automated crystallographic structure determination
journal, October 2002
- Adams, Paul D.; Grosse-Kunstleve, Ralf W.; Hung, Li-Wei
- Acta Crystallographica Section D Biological Crystallography, Vol. 58, Issue 11
Coot model-building tools for molecular graphics
journal, November 2004
- Emsley, Paul; Cowtan, Kevin
- Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
journal, May 1997
- Murshudov, G. N.; Vagin, A. A.; Dodson, E. J.
- Acta Crystallographica Section D Biological Crystallography, Vol. 53, Issue 3
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
journal, May 2007
- Davis, I. W.; Leaver-Fay, A.; Chen, V. B.
- Nucleic Acids Research, Vol. 35, Issue Web Server
Works referencing / citing this record:
Design, synthesis, and biologic evaluation of novel galloyl derivatives as HIV ‐1 RN ase H inhibitors
journal, January 2019
- Gao, Ping; Wang, Xueshun; Sun, Lin
- Chemical Biology & Drug Design, Vol. 93, Issue 4